Schering-Plough patent discloses novel gamma-secretase modulators for the treatment of AD April 9, 2009
GSK researchers describe new histamine H3 receptor antagonists for cognitive impairment April 8, 2009
New heterocyclic compounds in early development at AstraZeneca for the treatment of cancer April 8, 2009
Potassium channel modulators in early development at Valeant for the treatment of epilepsy April 7, 2009
RSS